387 related articles for article (PubMed ID: 26712781)
21. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
[TBL] [Abstract][Full Text] [Related]
22. Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence.
Carpentier A; Barez PY; Hamaidia M; Gazon H; de Brogniez A; Perike S; Gillet N; Willems L
Viruses; 2015 Jul; 7(7):3603-24. PubMed ID: 26198240
[TBL] [Abstract][Full Text] [Related]
23. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
[TBL] [Abstract][Full Text] [Related]
24. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
Kannagi M; Matsushita S; Shida H; Harada S
Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
[TBL] [Abstract][Full Text] [Related]
28. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
29. The immune response to HTLV-I.
Bangham CR
Curr Opin Immunol; 2000 Aug; 12(4):397-402. PubMed ID: 10899027
[TBL] [Abstract][Full Text] [Related]
30. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
31. Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence.
Sarkis S; Galli V; Moles R; Yurick D; Khoury G; Purcell DFJ; Franchini G; Pise-Masison CA
Retrovirology; 2019 Dec; 16(1):43. PubMed ID: 31852543
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.
Fukui S; Nakamura H; Takahashi Y; Iwamoto N; Hasegawa H; Yanagihara K; Nakamura T; Okayama A; Kawakami A
BMC Immunol; 2017 Feb; 18(1):7. PubMed ID: 28158970
[TBL] [Abstract][Full Text] [Related]
33. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
[TBL] [Abstract][Full Text] [Related]
34. Molecular Studies of HTLV-1 Replication: An Update.
Martin JL; Maldonado JO; Mueller JD; Zhang W; Mansky LM
Viruses; 2016 Jan; 8(2):. PubMed ID: 26828513
[TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immune response to human T-lymphotropic virus type I.
Mosley AJ; Asquith B; Bangham CR
Viral Immunol; 2005; 18(2):293-305. PubMed ID: 16035941
[TBL] [Abstract][Full Text] [Related]
36. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
Satou Y; Matsuoka M
Rev Med Virol; 2013 Sep; 23(5):269-80. PubMed ID: 23606621
[TBL] [Abstract][Full Text] [Related]
37. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
[TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
39. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
40. Neuronal molecular mimicry in immune-mediated neurologic disease.
Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
